The Clinical Impact of Flow Titration on Epoprostenol Delivery via High Flow Nasal Cannula for ICU Patients with Pulmonary Hypertension or Right Ventricular Dysfunction: A Retrospective Cohort Comparison Study

(1) Background: inhaled epoprostenol (iEPO) delivered via high-flow nasal cannula (HFNC) has been reported to be effective for pulmonary hypertension and right ventricular dysfunction. In vitro studies have identified HFNC gas flow as a key factor in trans-nasal aerosol delivery efficiency; however,...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jie, Gurnani, Payal K., Roberts, Keith M., Fink, James B., Vines, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074129/
https://www.ncbi.nlm.nih.gov/pubmed/32046152
http://dx.doi.org/10.3390/jcm9020464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074129/
https://www.ncbi.nlm.nih.gov/pubmed/32046152
http://dx.doi.org/10.3390/jcm9020464

Ejemplares similares